EUTECNIQ proposes to turn an international ingredient's evidence into a U.S.-ready file, then find and serve its U.S. buyers
For an ingredient manufacturer outside the United States that wants U.S. customers: what you would provide, what EUTECNIQ would do, the documents produced, the decisions along the way, and what is not promised.
Status. EUTECNIQ Sciences is a company in formation. It has no supplier agreements, no laboratory and no accreditation. Testing would be done by qualified external laboratories until EUTECNIQ has its own.
Your evidence, checked and completed for U.S. rules, with a defined commercial route at the end
Text version: situations, rules, steps and documents
Your situation
- Extract manufacturers with an established product Need verified evidence and a U.S. buyer route for an ingredient already sold elsewhere.
- Growers and primary processors Need identity, contaminant and quality records that U.S. buyers can verify.
- Makers of a new or changed ingredient Need a regulatory route for the intended U.S. use before anything ships.
U.S. rules your evidence serves
- 21 CFR 1, Subpart H Your own duty: register the facility with FDA.
- 21 CFR 1, Subpart I Prior notice before each shipment arrives.
- 21 CFR 1, Subpart L Your importer verifies you as a foreign supplier.
- 21 CFR 111.75 The supplement maker tests identity itself.
- 21 CFR 190.6 New dietary ingredient notification, when required.
Steps (proposed)
- Gap assessment Your documents against U.S. rules and buyer expectations.
- Qualification Audit plan, corrective actions, quality agreement.
- Verification testing Independent tests compared with your certificates.
- Regulatory strategy Category, NDI status, claims limits, import roles.
- Application work Formats and stability, where useful.
- U.S. route The chosen commercial model and buyer introductions.
Documents produced
In brief: what you would provide, what EUTECNIQ would do, what you would receive
Identity basis, process description, lot data, stability and safety information, regulatory and quality history, samples and commercial terms.
Gap assessment, supplier qualification, verification testing through partner laboratories, specification, regulatory strategy, application work and a U.S. commercial route.
ProposedA defined set of documents with agreed ownership, and a decision at each step on whether to continue.
U.S. buyers must verify what they buy, and U.S. rules decide what an ingredient may be used for. EUTECNIQ would close the distance between your current documentation and both.
The work starts from what your company already knows about its ingredient and its process
Only the first row is needed before an NDA. Everything else would be shared under a mutual NDA, in a controlled data room.
Text version: the ten kinds of information, what each includes and why it is needed
| Information | What it includes | Why it is needed |
|---|---|---|
| Non-confidential summary | Ingredient name and form, plant species and part, intended U.S. uses, existing certifications, company contact | Decide whether there is a fit before anything confidential is exchanged |
| Botanical identity basis | Latin binomial with author, plant part, geographic origin, cultivated or wild-collected, any voucher or reference material | Identity method design; a U.S. new-dietary-ingredient notification names a botanical by its Latin binomial including the author (21 CFR 190.6(b)) |
| Process description | Extraction solvents, ratio of raw material to extract, concentration and drying steps, carriers and excipients | Composition, residual solvents, and whether the process changes regulatory status |
| Lot data | Current specification and certificates of analysis for several recent lots, with methods, limits and actual results | Baseline for verification testing and for a buyer's reliance on certificates |
| Stability | Study protocol, results and packaging | Retest date under shipping and storage conditions |
| Safety information | Toxicology studies, history of use, published literature, adverse-event information | Safety evidence and its gaps for the intended use and intake |
| Regulatory and import history | FDA food facility registration status, U.S. shipments, refusals or import alerts, authorizations in other markets | Import risk and the regulatory starting point |
| Quality system | Certifications, recent audit reports, complaint, deviation and recall history | Supplier qualification and audit planning |
| Commercial terms | Capacity, lead times, minimum order, pricing structure and trade term, preferred U.S. model | Choice of commercial model and landed-cost assessment |
| Development samples | Representative lots shipped with full documentation | Verification testing; FDA prior notice applies to samples imported for testing (21 CFR 1.277(a)) |
EUTECNIQ would close the gap between your documentation and what U.S. buyers and rules require
Each step would be scoped and priced before it starts.
Text version of the steps and roles
- Gap assessmentYour documents against U.S. rules and buyer expectations
- QualificationAudit, corrective actions, draft quality agreement
- VerificationIndependent testing, fingerprint, specification
- Regulatory strategyCategory, NDI status, claims limits, import roles
- Application workFormats and stability, where useful
- U.S. routeDistribution, representation, co-development or private label
- Plans the work and owns the gap assessment and specification
- Reviews all laboratory data and audit findings
- Prepares the regulatory market-access file and U.S. technical data package
- Presents the ingredient to U.S. buyers under the chosen model
- External laboratories for identity, fingerprint, contaminant and stability testing
- Third-party auditors where an on-site audit is needed and EUTECNIQ cannot attend
- Regulatory and commercial counsel for legal conclusions and agreements
- Customs brokers and warehouses once goods move
Each step ends in a named document whose ownership is agreed before the work starts
Default ownership is a starting proposal for negotiation.
Text version: contents and default ownership of each document
| Document | Contents | Proposed default ownership |
|---|---|---|
| Gap assessment report | What U.S. buyers and rules need, what exists, what is missing, and the cost and time to close each gap | Supplier, when the supplier pays for it |
| Supplier qualification dossier | Audit findings and corrective actions, manufacturing controls, draft quality agreement, traceability description | Shared; buyers see it only with the supplier's consent |
| Ingredient identity passport | Authentication basis, plant part and source, fingerprint, specification, reference materials | Set by the agreement |
| Specification with justification | Each limit for identity, purity, strength, composition and contaminants, with its method and reason | Set by the agreement; under private label, EUTECNIQ |
| Verification test summary | Independent results on several lots compared with your certificates of analysis | Party that paid for the testing |
| Regulatory market-access file | Intended-use category, NDI status memo, claims boundaries, FSVP role plan, draft notification where needed | Set by the agreement, including rights to reference it |
| U.S. technical data package | Technical and safety data sheets, allergen and composition statements, certificate template | Supplier |
| Commercial term sheet | Model, territory, exclusivity scope, minimums, pricing mechanism, term | Both parties |
Who may file a new dietary ingredient notification: the manufacturer or distributor of the ingredient or of the supplement (21 CFR 190.6(a)). EUTECNIQ's methods, templates and know-how would remain its background IP; see commercialization and licensing.
Six decisions would let either side stop early, before cost accumulates
Each decision would be taken on written evidence; stopping is a normal outcome.
Text version of the six decisions
| Decision | Question | If the answer is no |
|---|---|---|
| 1. Initial fit | Does the ingredient have a plausible U.S. use and buyer group? | Decline politely, before any NDA |
| 2. Scope and fee | After document review, is the gap closable at a cost both sides accept? | Stop; the summary of gaps is shared |
| 3. Qualification | Do the audit and verification tests support approval? | Corrective actions and retest, or stop |
| 4. Regulatory pathway | Is there a lawful U.S. pathway for the intended use with evidence that can be produced? | Change the intended use, plan the evidence, or stop |
| 5. Commercial model | Which model fits, with what exclusivity, minimums and term? | Keep the documents; no distribution agreement |
| 6. First commercial lots | Do lots clear entry, meet specification on receipt and pass customer qualification? | Investigation and corrective action before further shipments |
Twenty-six CFR rule sets touch an imported botanical ingredient; most are duties of your U.S. importer or buyer
Data table: every rule set in the treemap
| Rule set | What it covers | Agency group | eCFR sections | Level |
|---|---|---|---|---|
| 21 CFR Part 111 | Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements. CGMP for anyone who makes, packages, labels or holds a dietary supplement, including identity tests of dietary ingredients. | FDA · 21 CFR | 84 | Check |
| 21 CFR Part 117 | Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food. CGMP, hazard analysis and preventive controls for human food, including dietary ingredients. | FDA · 21 CFR | 61 | Applies |
| 21 CFR Part 101 | Food Labeling. Food labels: Supplement Facts (§ 101.36), health claims (§ 101.14) and structure/function statements (§ 101.93). | FDA · 21 CFR | 50 | Check |
| 21 CFR Part 1, Subpart R | Laboratory Accreditation for Analyses of Foods. Certain food tests, such as tests to support admission of an import, must be run by a LAAF-accredited laboratory. | FDA · 21 CFR | 42 | Check |
| 21 CFR Part 1, Subpart O | Sanitary Transportation of Human and Animal Food. Shippers, loaders, carriers and receivers keep food safe during transport; § 1.900(b) lists exempt operations. | FDA · 21 CFR | 18 | Check |
| 21 CFR Part 1, Subpart L | Foreign Supplier Verification Programs for Food Importers. Importers verify that foreign suppliers produce food safely; § 1.511 modifies the program for dietary supplements. | FDA · 21 CFR | 15 | Applies |
| 21 CFR Part 1, Subpart H | Registration of Food Facilities. Facilities that make, process, pack or hold food for U.S. consumption register with FDA and renew every two years. | FDA · 21 CFR | 14 | Applies |
| 21 CFR Part 1, Subpart J | Establishment, Maintenance, and Availability of Records. Keep records of the immediate previous source and the immediate subsequent recipient of food. | FDA · 21 CFR | 13 | Applies |
| 21 CFR Part 1, Subpart D | Electronic Import Entries. Lists the data FDA needs in each electronic customs entry of an FDA-regulated article. | FDA · 21 CFR | 12 | Applies |
| 21 CFR Part 1, Subpart I | Prior Notice of Imported Food. Imported food needs prior notice to FDA: at least 2 hours before arrival by road, 4 by rail or air, 8 by water. | FDA · 21 CFR | 10 | Applies |
| 21 CFR Part 7, Subpart C | Enforcement Policy. FDA's recall policy: recalls are voluntary actions, classified by health hazard, with a recall strategy. | FDA · 21 CFR | 10 | Check |
| 21 CFR Part 11 | Electronic Records; Electronic Signatures. Electronic records and signatures that meet FDA record rules must be trustworthy, reliable and equivalent to paper. | FDA · 21 CFR | 10 | Applies |
| 21 CFR Part 1, Subpart E | Imports and Exports. FDA import sampling, hearings and relabeling of refused goods, and the records kept for certain exports. | FDA · 21 CFR | 9 | Check |
| 21 CFR Part 190 | Dietary Supplements. A new dietary ingredient needs notification to FDA at least 75 days before marketing, unless the food-supply exception applies. | FDA · 21 CFR | 1 | Check |
| 19 CFR Part 141 | Entry of Merchandise. Entry of merchandise: liability for duties, who may enter, invoices, duty deposits and release. | Trade: CBP, OFAC, FWS | 69 | Applies |
| 19 CFR Part 113 | CBP Bonds. Customs bonds that secure payment of duties and compliance with import rules. | Trade: CBP, OFAC, FWS | 53 | Applies |
| 19 CFR Part 142 | Entry Process. The entry process: entry documents, entry summary, immediate delivery and line release. | Trade: CBP, OFAC, FWS | 40 | Applies |
| 19 CFR Part 134 | Country of Origin Marking. Country-of-origin marking of imported articles or their containers (§ 134.11). | Trade: CBP, OFAC, FWS | 33 | Applies |
| 19 CFR Part 177 | Administrative Rulings. Binding advance rulings from CBP, for example on tariff classification. | Trade: CBP, OFAC, FWS | 25 | Check |
| 19 CFR Part 152 | Classification and Appraisement of Merchandise. Tariff classification and customs valuation of imported goods. | Trade: CBP, OFAC, FWS | 21 | Applies |
| 19 CFR Part 12 (selected subject groups) | Special Classes of Merchandise. CBP rules for FDA-regulated goods (§ 12.1), plants, goods made with forced labor, and goods under sanctions. | Trade: CBP, OFAC, FWS | 16 | Applies |
| 19 CFR Part 149 | Importer Security Filing. Importer Security Filing for ocean cargo; core data due 24 hours before loading at the foreign port. | Trade: CBP, OFAC, FWS | 6 | Check |
| 7 CFR Part 319 | Foreign Quarantine Notices. Conditions for importing plants and plant products that can carry pests; they depend on the commodity and origin. | USDA · 7 CFR | 128 | Check |
| 7 CFR Part 330 | Federal Plant Pest Regulations; General; Plant Pests, Biological Control Organisms, and Associated Articles; Garbage. Restrictions on moving plant pests, biological control organisms and associated articles, and on garbage. | USDA · 7 CFR | 24 | Check |
| 7 CFR Part 357 | Control of Illegally Taken Plants. Lacey Act plant declaration (§ 357.3): required for tariff codes on APHIS's phase-in schedule; "plant" excludes common cultivars and common food crops (§ 357.2). CFR atlas | USDA · 7 CFR | 4 | Check |
| 40 CFR Part 180 | Tolerances and Exemptions for Pesticide Chemical Residues in Food. Tolerances and exemptions for pesticide residues in food; inert-ingredient exemptions are in §§ 180.910–180.960. | EPA · 40 CFR | 755 | Applies |
| Total | 26 rule sets; 14 apply, the rest apply only in the circumstances they name | 1523 | 1122 in rules that apply |
No regulatory outcome, sale or exclusivity would be promised before evidence and a signed agreement exist
- FDA's acknowledgment of a notification≠FDA approval of the ingredient
- FDA's silence on a notification≠A finding that the ingredient is safe (21 CFR 190.6(f))
- A GRAS conclusion≠A conclusion that cannot be challenged
- Work toward U.S. buyers≠A promised volume, price, customer or exclusivity
- A report from EUTECNIQ≠A certification
- EUTECNIQ's support≠A transfer of your duties: facility registration, manufacturing practice, data accuracy
- A foreign GMP certificate or U.S. status≠U.S. marketability, or status in any other market
- Your certificate of analysis≠A buyer's own identity test (21 CFR 111.75(a)(1))
Text version: the five limits
- No regulatory outcome. FDA approves neither dietary ingredients nor notifications; its silence is not a finding of safety. A GRAS conclusion can be challenged.
- No volume, price, customer or exclusivity before a signed agreement.
- No certification: reports would be evidence for buyers.
- Your duties stay yours: facility registration, manufacturing practice, data accuracy.
- One market at a time: U.S. work does not establish status elsewhere.
Nothing confidential would be requested before a mutual NDA is signed
Text version of the five stages
- First contact. A non-confidential summary only.
- Mutual NDA. Defines confidential information, use for evaluation only, no analysis of samples beyond the agreed tests, term, and return or destruction.
- Data room. Dossiers, process details and audit reports shared in a controlled folder with access logging.
- Development agreement. Ownership of new data and reports, rights to reference them in regulatory files, and publication only with consent.
- Before any filing. FDA keeps a new dietary ingredient notification confidential for 90 days, then makes it public except trade secrets and confidential commercial information (21 CFR 190.6(e)). What is marked confidential is planned before filing.
EUTECNIQ would not use one supplier's confidential data for another supplier's product.
Start with a non-confidential summary
Send the ingredient, plant species and part, form, intended U.S. uses and existing certifications. A reply would say whether there is a fit and propose an NDA.